
Bullish Breakout: Glenmark Pharma Surges On AbbVie Deal, SEBI RA Sees Long-Term Gains
A $1.9 billion deal with AbbVie has sent Glenmark shares soaring to a 52-week high. The analyst says the move validates Glenmark’s innovation push and opens new global revenue streams. Glenmark Pharmaceuticals shares surged 15% on Friday, hitting a fresh …